Clinical trial

Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain…

NCT00469937 · Vanderbilt-Ingram Cancer Center, Other · Terminated

Key facts

NCT number NCT00469937
Title Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases
Official title A Phase I Study of Lithium During Whole Brain Radiotherapy for Patients With Brain Metastases
Lead sponsor Vanderbilt-Ingram Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Neurotoxicity, Solid Tumor
Intervention type Drug, Procedure, Radiation
Interventions lithium carbonate, cognitive assessment, quality-of-life assessment, radiation therapy
Enrollment 9
Start date Feb 1, 2006
Primary completion Mar 1, 2009
Completion Mar 1, 2009
First posted May 7, 2007
Last update posted Feb 28, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies